Specialty code 1835P2201X · Union City, CA
NPI
1336625193
Since 2018
Specialty
Specialty code 1835P2201X
Code 1835P2201X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
30116 Eigenbrodt Way
Union City, CA, 94587
Phone (510) 675-6684
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$264K
2,084 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Brian Allan C Macapinlac prescribed most often to Medicare patients was Atorvastatin Calcium, with 356 prescriptions and refills. In total Brian Allan C Macapinlac wrote 2,084 Medicare prescriptions that cost $264K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 356 | 1,182 | 130 | $4,538 |
| Metformin Hcl Er Metformin Hcl | 189 | 622 | 78 | $1,923 |
| Glipizide Generic | 174 | 566 | 68 | $2,051 |
| Metformin Hcl Generic | 128 | 424 | 53 | $1,553 |
| Humulin N Insulin Nph Human Isophane | 126 | 382 | 56 | $26K |
| Ozempic Semaglutide | 119 | 121 | 27 | $89K |
| Jardiance Empagliflozin | 117 | 387 | 51 | $65K |
| Insulin Glargine-Yfgn Generic | 71 | 204 | 38 | $11K |
| Glipizide Er Glipizide | 68 | 222 | 25 | $2,026 |
| Losartan Potassium Generic | 59 | 197 | 23 | $749 |
| Lisinopril Generic | 58 | 191 | 22 | $676 |
| Humulin R Insulin Regular, Human | 57 | 168 | 25 | $9,584 |
| Amlodipine Besylate Generic | 49 | 159 | 20 | $580 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 48 | 142 | 18 | $1,211 |
| Simvastatin Generic | 44 | 147 | 17 | $513 |
Brand drugs: 601 claims; generic drugs: 1,292 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Brian Allan C Macapinlac were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.